The expression of claudin-3 in ovarian, prostate, breast, pancreatic and lung cancers could promote tumor invasion and development, but the effect of claudin-3 on melanoma progression and metastasis has not been addressed so far. This evidence concerns the gene CLDN3 and lung cancer.